Compare SCNX & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCNX | MDRR |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 18.3M |
| IPO Year | 2019 | 2015 |
| Metric | SCNX | MDRR |
|---|---|---|
| Price | $2.93 | $10.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 50.6K | 1.0K |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.74 |
| Revenue | $3,831,778.00 | ★ $10,396,618.00 |
| Revenue This Year | $1,009.57 | $0.91 |
| Revenue Next Year | $259.51 | $1.70 |
| P/E Ratio | ★ N/A | $2.26 |
| Revenue Growth | ★ 30.72 | 6.79 |
| 52 Week Low | $3.21 | $9.47 |
| 52 Week High | $106.25 | $14.52 |
| Indicator | SCNX | MDRR |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 45.78 |
| Support Level | N/A | $9.51 |
| Resistance Level | $11.68 | $12.23 |
| Average True Range (ATR) | 8.43 | 0.44 |
| MACD | -1.26 | -0.08 |
| Stochastic Oscillator | 0.09 | 36.62 |
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.